New Strategies in Head and Neck Cancer: Understanding Resistance to Epidermal Growth Factor Receptor Inhibitors

被引：90
作者：
Chen, Lucy F. [1 ]
Cohen, Ezra E. W. [1 ]
Grandis, Jennifer R. [2 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
来源：
CLINICAL CANCER RESEARCH | 2010年 / 16卷 / 09期
关键词：
SQUAMOUS-CELL CARCINOMA; TYROSINE KINASE INHIBITORS; LUNG-CANCER; PLUS CETUXIMAB; CONSTITUTIVE ACTIVATION; MESENCHYMAL TRANSITION; ACQUIRED-RESISTANCE; PHASE-II; IN-SITU; EGFR;
D O I：
10.1158/1078-0432.CCR-09-2318
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The epidermal growth factor receptor (EGFR) is a validated target in squamous cell carcinoma of the head and neck (HNSCC). However, despite high expression of EGFR in these cancers, EGFR inhibitor monotherapy has only had modest activity. Potential mechanisms of resistance to EGFR-targeted therapies involve EGFR and Ras mutations, epithelial-mesenchymal transition, and activation of alternative and downstream pathways. Strategies to optimize EGFR-targeted therapy in head and neck cancer involve not only the selection for patients most likely to benefit but also the use of combination therapies to target the network of pathways involved in tumor growth, invasion, angiogenesis, and metastasis. Clin Cancer Res; 16(9); 2489-95. (C) 2010 AACR.
引用
收藏
页码：2489 / 2495
页数：7
相关论文
共 50 条
[31]   Stepwise progress in epidermal growth factor receptor/radiation studies for head and neck cancer [J].
Harari, Paul M. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (02) :S25-S27
[32]   MECHANISMS OF RESISTANCE TO EGFR INHIBITORS IN HEAD AND NECK CANCER [J].
Cooper, Jonathan B. ;
Cohen, Ezra Eddy Wyssam .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2009, 31 (08) :1086-1094
[33]   Epidermal growth factor receptor-mutated lung carcinomas with insufficient response to epidermal growth factor receptor inhibitors [J].
Moiseenko, Fedor ;
Kuligina, Ekaterina ;
Elsakova, Ekaterina ;
Imyanitov, Evgeny .
FUTURE ONCOLOGY, 2024, 20 (31) :2397-2407
[34]   Gene expression signatures modulated by epidermal growth factor receptor activation and their relationship to cetuximab resistance in head and neck squamous cell carcinoma [J].
Fertig, Elana J. ;
Ren, Qing ;
Cheng, Haixia ;
Hatakeyama, Hiromitsu ;
Dicker, Adam P. ;
Rodeck, Ulrich ;
Considine, Michael ;
Ochs, Michael F. ;
Chung, Christine H. .
BMC GENOMICS, 2012, 13
[35]   A new analysis approach of epidermal growth factor receptor pathway activation patterns provides insights into cetuximab resistance mechanisms in head and neck cancer [J].
Silvia von der Heyde ;
Tim Beissbarth .
BMC Medicine, 10
[36]   A new analysis approach of epidermal growth factor receptor pathway activation patterns provides insights into cetuximab resistance mechanisms in head and neck cancer [J].
von der Heyde, Silvia ;
Beissbarth, Tim .
BMC MEDICINE, 2012, 10
[37]   Early investigational drugs that target epidermal growth factor receptors for the treatment of head and neck cancer [J].
Ugurluer, Gamze ;
Ozsahin, Mahmut .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (12) :1637-1654
[38]   Growth factor expression mediates resistance to EGFR inhibitors in head and neck squamous cell carcinomas [J].
Tepper, Susanne R. ;
Zuo, Zhixiang ;
Khattri, Arun ;
Hess, Jochen ;
Seiwert, Tanguy Y. .
ORAL ONCOLOGY, 2016, 56 :62-70
[39]   Concurrent radiotherapy plus epidermal growth factor receptor inhibitors in patients with human papillomavirus-related head and neck cancer [J].
Pajares, B. ;
Perez-Villa, L. ;
Trigo, J. M. ;
Toledo, M. D. ;
Alvarez, M. ;
Jimenez, B. ;
Medina, J. A. ;
de Luque, V. ;
Jerez, J. M. ;
Alba, E. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (04) :418-424
[40]   Epidermal growth factor receptor (EGF) in head-and-neck cancers [J].
Bourhis, J. ;
Tao, Y. G. ;
Zhang, P. ;
Deutsch, E. .
BULLETIN DU CANCER, 2007, 94 :F189-F191
12345